# Combination antiretroviral therapy: Industries

Source page: https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-industries/

#### Industries

The industries and kinds of firm that use or make it, how far they have taken it up and what it does to them
 Made by

- [Innovator pharma and biotech companies](https://www.materialinsights.org/industries/pharmaceuticals/) New drug classes Research-based drug companies, with NIH-funded research, developed the drug classes from AZT in 1987 onwards ^[1].
- [Finished-dose formulators (branded and generic)](https://www.materialinsights.org/industries/pharmaceuticals/) low-cost generics Generic producers in countries such as India, Brazil and Thailand ^[4] helped bring the lowest first-line price to $100 a year by 2016 ^[5].
 Used by

- [Primary care clinics and doctors' practices](https://www.materialinsights.org/industries/healthcare/) Lifelong treatment Clinics test, treat and monitor 32.1 million people on treatment in 2025 ^[2].
- [Public hospitals, schools and universities](https://www.materialinsights.org/industries/public_admin/) National programmes Public health programmes fund and run treatment; US$ 17.6 billion was available in poorer countries at the end of 2025 ^[2].

as of 2026-11-11

#### Sources

1. [Antiretroviral Drug Discovery and Development](https://www.niaid.nih.gov/diseases-conditions/antiretroviral-drug-development) National Institute of Allergy and Infectious Diseases (NIH)
2. [Fact sheet 2026](https://www.unaids.org/sites/default/files/2026-07/2026_UNAIDS_Global_HIV_Factsheet_en.pdf) UNAIDS, 2026
3. [The impact of patents on access to medicines](https://msfaccess.org/impact-patents-access-medicines) MSF Access Campaign (Médecins Sans Frontières), 2017
4. [Untangling the Web of Antiretroviral Price Reductions, 18th edition](https://new.aidsdatahub.org/sites/default/files/resource/msf-untangling-web-antiretroviral-price-reductions-18th-edition-2016.pdf) Médecins Sans Frontières Access Campaign, copy at AIDS Data Hub, 2016, p. 3

## Other sections

- [Summary](https://www.materialinsights.org/technologies/antiretroviral_therapy/index.md)
- [Overview](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-overview/index.md)
- [Science](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-evolution/index.md)
- [Materials](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-energy-footprint/index.md)
